AVTE
Price
$2.72
Change
-$0.02 (-0.73%)
Updated
Apr 24 closing price
Capitalization
78.84M
24 days until earnings call
OVID
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Apr 24 closing price
Capitalization
23.94M
13 days until earnings call
Ad is loading...

AVTE vs OVID

Header iconAVTE vs OVID Comparison
Open Charts AVTE vs OVIDBanner chart's image
Aerovate Therapeutics
Price$2.72
Change-$0.02 (-0.73%)
Volume$4.84M
Capitalization78.84M
Ovid Therapeutics
Price$0.34
Change+$0.02 (+6.25%)
Volume$768.73K
Capitalization23.94M
AVTE vs OVID Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. OVID commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Buy and OVID is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AVTE: $2.72 vs. OVID: $0.34)
Brand notoriety: AVTE and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 1744% vs. OVID: 206%
Market capitalization -- AVTE: $78.84M vs. OVID: $23.94M
AVTE [@Biotechnology] is valued at $78.84M. OVID’s [@Biotechnology] market capitalization is $23.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileOVID’s FA Score has 1 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, AVTE is a better buy in the long-term than OVID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 7 TA indicator(s) are bullish while OVID’s TA Score has 4 bullish TA indicator(s).

  • AVTE’s TA Score: 7 bullish, 4 bearish.
  • OVID’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AVTE is a better buy in the short-term than OVID.

Price Growth

AVTE (@Biotechnology) experienced а -1.09% price change this week, while OVID (@Biotechnology) price change was +16.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

AVTE is expected to report earnings on Aug 11, 2025.

OVID is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTE($78.8M) has a higher market cap than OVID($23.9M). AVTE YTD gains are higher at: 2.642 vs. OVID (-63.928). OVID has higher annual earnings (EBITDA): -61.27M vs. AVTE (-89.96M). AVTE has more cash in the bank: 88.7M vs. OVID (53.1M). AVTE has less debt than OVID: AVTE (540K) vs OVID (14.8M). OVID has higher revenues than AVTE: OVID (566K) vs AVTE (0).
AVTEOVIDAVTE / OVID
Capitalization78.8M23.9M330%
EBITDA-89.96M-61.27M147%
Gain YTD2.642-63.928-4%
P/E RatioN/AN/A-
Revenue0566K-
Total Cash88.7M53.1M167%
Total Debt540K14.8M4%
FUNDAMENTALS RATINGS
OVID: Fundamental Ratings
OVID
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTEOVID
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDGR26.130.67
+2.63%
Schrodinger
ADDYY123.290.17
+0.14%
adidas AG
CIADY24.17-0.67
-2.70%
China Mengniu Dairy Co., Ltd.
ELUT2.17-0.12
-5.24%
Elutia
JACK23.97-1.46
-5.72%
Jack In The Box

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
-0.73%
OVID - AVTE
89%
Closely correlated
+3.63%
NTLA - AVTE
46%
Loosely correlated
+1.11%
DNLI - AVTE
43%
Loosely correlated
+4.17%
BEAM - AVTE
41%
Loosely correlated
+1.51%
SNDX - AVTE
39%
Loosely correlated
+2.31%
More

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with AVTE. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then AVTE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+3.63%
AVTE - OVID
88%
Closely correlated
-0.73%
SYRE - OVID
46%
Loosely correlated
+4.99%
NAUT - OVID
36%
Loosely correlated
-3.92%
KPRX - OVID
36%
Loosely correlated
+2.56%
TVTX - OVID
36%
Loosely correlated
+5.57%
More